glypican 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| branching involved in ureteric bud morphogenesis | ||
| kidney development | ||
| smoothened signaling pathway | ||
| negative regulation of cell population proliferation | ||
| response to bacterium |
| GO Term | Evidence Code | PMID |
|---|---|---|
| lysosome | ||
| Golgi lumen | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding | ||
| peptidyl-dipeptidase inhibitor activity | ||
| peptidyl-dipeptidase inhibitor activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060248 | Simpson-Golabi-Behmel syndrome type 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026